{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:07:52Z","timestamp":1762459672541,"version":"3.37.3"},"reference-count":47,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2013-6615","2011-3435","SB12-0072"],"award-info":[{"award-number":["2013-6615","2011-3435","SB12-0072"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI089894","R01AI126887"],"award-info":[{"award-number":["R01AI089894","R01AI126887"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007268","name":"Washington University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5I01BX001469"],"award-info":[{"award-number":["5I01BX001469"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2019.01.016","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T12:20:47Z","timestamp":1548764447000},"page":"4805-4810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0007-3229","authenticated-orcid":false,"given":"Lynda","family":"Mottram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhra","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4281-2990","authenticated-orcid":false,"given":"Eric","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Fleckenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.01.016_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.10.011","article-title":"WHO consultation on ETEC and Shigella burden of disease, Geneva, 6\u20137th April 2017: Meeting report","author":"Hosangadi","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.016_b0010","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1016\/j.vaccine.2017.09.045","article-title":"Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE conference","volume":"35","author":"Walker","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.016_b0015","doi-asserted-by":"crossref","DOI":"10.1098\/rspb.2015.0488","article-title":"Genomic perspectives on the evolution and spread of bacterial pathogens","volume":"282","author":"Bentley","year":"2015","journal-title":"Proc Royal Soc B: Biol Sci"},{"key":"10.1016\/j.vaccine.2019.01.016_b0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/ijms18010158","article-title":"Reverse vaccinology: An approach for identifying leptospiral vaccine candidates","volume":"18","author":"Dellagostin","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2019.01.016_b0025","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012476","article-title":"Vaccines, reverse vaccinology, and bacterial pathogenesis","volume":"3","author":"Delany","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.vaccine.2019.01.016_b0030","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12406","article-title":"Helicobacter: Inflammation, immunology and vaccines","volume":"22","author":"Robinson","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.vaccine.2019.01.016_b0035","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.tube.2016.05.010","article-title":"TB biomarkers, TB correlates and human challenge models: New tools for improving assessment of new TB vaccines","volume":"99","author":"Kaufmann","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2019.01.016_b0040","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3389\/fimmu.2017.01839","article-title":"Transcriptomics in human challenge models","volume":"8","author":"Barton","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.01.016_b0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/17460441.2018.1413088","article-title":"The use of databases, data mining and immunoinformatics in vaccinology: where are we?","volume":"13","author":"Hegde","year":"2018","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.vaccine.2019.01.016_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005457","article-title":"Transcriptomics technologies","volume":"13","author":"Lowe","year":"2017","journal-title":"PLOS Comput Biol"},{"key":"10.1016\/j.vaccine.2019.01.016_b0055","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1128\/IAI.02006-05","article-title":"The major subunit, CfaB, of colonization factor antigen i from enterotoxigenic Escherichia coli is a glycosphingolipid binding protein","volume":"74","author":"Jansson","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.01.016_b0060","doi-asserted-by":"crossref","first-page":"11250","DOI":"10.1038\/s41598-018-29258-0","article-title":"Glyco-engineered cell line and computational docking studies reveals enterotoxigenic Escherichia coli CFA\/I fimbriae bind to Lewis a glycans","volume":"8","author":"Mottram","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.01.016_b0065","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1128\/IAI.01571-08","article-title":"Children with the Le(a+b-) blood group have increased susceptibility to diarrhea caused by enterotoxigenic Escherichia coli expressing colonization factor I group fimbriae","volume":"77","author":"Ahmed","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.01.016_b0070","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/CMR.00109-14","article-title":"Blood groups in infection and host susceptibility","volume":"28","author":"Cooling","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2019.01.016_b0075","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41598-018-19718-y","article-title":"The Lewis A phenotype is a restriction factor for Rotateq and Rotarix vaccine-take in Nicaraguan children","volume":"8","author":"Bucardo","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.01.016_b0080","doi-asserted-by":"crossref","unstructured":"The 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56\u201365.","DOI":"10.1038\/nature11632"},{"key":"10.1016\/j.vaccine.2019.01.016_b0085","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baw093","article-title":"The Ensembl gene annotation system","author":"Aken","year":"2016","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.vaccine.2019.01.016_b0090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.vaccine.2019.01.016_b0095","doi-asserted-by":"crossref","first-page":"10649","DOI":"10.1038\/s41598-017-10854-5","article-title":"FUT2 non-secretor status is associated with altered susceptibility to symptomatic enterotoxigenic Escherichia coli infection in Bangladeshis","volume":"7","author":"Mottram","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.01.016_b0100","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1128\/IAI.00459-07","article-title":"Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh","volume":"75","author":"Qadri","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.01.016_b0105","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1128\/IAI.72.3.1786-1794.2004","article-title":"Identification and molecular characterization of EatA, an autotransporter protein of enterotoxigenic Escherichia coli","volume":"72","author":"Patel","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.01.016_b0110","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1128\/IAI.74.4.2245-2258.2006","article-title":"Identification of a two-partner secretion locus of enterotoxigenic Escherichia coli","volume":"74","author":"Fleckenstein","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.01.016_b0115","doi-asserted-by":"crossref","DOI":"10.1145\/2818302","article-title":"Conservation and immunogenicity of novel antigens in diverse isolates of enterotoxigenic Escherichia coli","volume":"9","author":"Luo","year":"2015","journal-title":"PLoS NeglTrop Dis"},{"key":"10.1016\/j.vaccine.2019.01.016_b0120","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/infdis\/jiy312","article-title":"Human experimental challenge with enterotoxigenic escherichia coli elicits immune responses to canonical and novel antigens relevant to vaccine development","volume":"218","author":"Chakraborty","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.016_b0125","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1128\/IAI.01078-13","article-title":"EatA, an immunogenic protective antigen of enterotoxigenic Escherichia coli, degrades intestinal mucin","volume":"82","author":"Kumar","year":"2014","journal-title":"Infect Immunity"},{"key":"10.1016\/j.vaccine.2019.01.016_b0130","doi-asserted-by":"crossref","first-page":"45270","DOI":"10.1038\/srep45270","article-title":"A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions","volume":"7","author":"Noel","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.01.016_b0135","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nature07568","article-title":"Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells","volume":"457","author":"Roy","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.01.016_b0140","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1172\/JCI97659","article-title":"Enterotoxigenic Escherichia coli\u2013blood group A interactions intensify diarrheal severity","volume":"128","author":"Kumar","year":"2018","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2019.01.016_b0145","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4269\/ajtmh.16-0161","article-title":"Blood group O-dependent cellular responses to cholera toxin: parallel clinical and epidemiological links to severe cholera","volume":"95","author":"Kuhlmann","year":"2016","journal-title":"Am J Tropical Med Hygiene"},{"key":"10.1016\/j.vaccine.2019.01.016_b0150","article-title":"Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers","volume":"12","author":"Chakraborty","year":"2018","journal-title":"PLoS NeglTrop Dis"},{"key":"10.1016\/j.vaccine.2019.01.016_b0155","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/infdis\/jiv593","article-title":"Transcriptomic analysis of the host response and innate resilience to enterotoxigenic Escherichia coli infection in humans","volume":"213","author":"Yang","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.016_b0160","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12864-016-2777-0","article-title":"Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment","volume":"17","author":"Pop","year":"2016","journal-title":"BMC Genomics"},{"key":"10.1016\/j.vaccine.2019.01.016_b0165","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s003359900556","article-title":"Two alpha(1,2) fucosyltransferase genes on porcine chromosome 6q11 are closely linked to the blood group inhibitor (S) and Escherichia coli F18 receptor (ECF18R) loci","volume":"8","author":"Meijerink","year":"1997","journal-title":"Mamm Genome"},{"key":"10.1016\/j.vaccine.2019.01.016_b0170","first-page":"479","article-title":"A molecular test for the detection of E. coli F18 receptors: a breakthrough in the struggle against edema disease and post-weaning diarrhea in swine","volume":"139","author":"Vogeli","year":"1997","journal-title":"Schweiz Arch Tierheilkd"},{"key":"10.1016\/j.vaccine.2019.01.016_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023309","article-title":"Erythrocyte and porcine intestinal glycosphingolipids recognized by F4 fimbriae of enterotoxigenic Escherichia coli","volume":"6","author":"Coddens","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.01.016_b0180","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1074\/jbc.M807866200","article-title":"Recognition of blood group ABH type 1 determinants by the FedF adhesin of F18-fimbriated Escherichia coli","volume":"284","author":"Coddens","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2019.01.016_b0185","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2958.2012.08174.x","article-title":"Structural insight in histo-blood group binding by the F18 fimbrial adhesin FedF","volume":"86","author":"Moonens","year":"2012","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2019.01.016_b0190","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.vetmic.2007.02.007","article-title":"The age-dependent expression of the F18+E. coli receptor on porcine gut epithelial cells is positively correlated with the presence of histo-blood group antigens","volume":"122","author":"Coddens","year":"2007","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.01.016_b0195","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vetmic.2016.01.014","article-title":"High susceptibility prevalence for F4+ and F18+Escherichia coli in Flemish pigs","volume":"202","author":"Nguyen","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.01.016_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105013","article-title":"Refined candidate region for F4ab\/ac enterotoxigenic Escherichia coli susceptibility situated proximal to MUC13 in pigs","volume":"9","author":"Goetstouwers","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.01.016_b0205","doi-asserted-by":"crossref","first-page":"70","DOI":"10.12688\/wellcomeopenres.12256.1","article-title":"A framework for controlled human infection model (CHIM) studies in Malawi: Report of a wellcome trust workshop on CHIM in low income countries held in Blantyre, Malawi","volume":"2","author":"Gordon","year":"2017","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.vaccine.2019.01.016_b0210","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1016\/j.vaccine.2015.09.059","article-title":"Large screen approaches to identify novel malaria vaccine candidates","volume":"33","author":"Davies","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.016_b0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s10038-017-0376-9","article-title":"CRISPR\/Cas9 library screening for drug target discovery","volume":"63","author":"Kurata","year":"2018","journal-title":"J Hum Genet"},{"key":"10.1016\/j.vaccine.2019.01.016_b0220","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1093\/nar\/gky550","article-title":"High-throughput antibody engineering in mammalian cells by CRISPR\/Cas9-mediated homology-directed mutagenesis","volume":"46","author":"Mason","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2019.01.016_b0225","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg3899","article-title":"High-throughput functional genomics using CRISPR-Cas9","volume":"16","author":"Shalem","year":"2015","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.vaccine.2019.01.016_b0230","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cell.2013.06.022","article-title":"Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes","volume":"154","author":"White Jacqueline","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2019.01.016_b0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41576-018-0051-9","article-title":"Progress and potential in organoid research","author":"Rossi","year":"2018","journal-title":"Nat Rev Genet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T00:46:06Z","timestamp":1569026766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19300696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":47,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X19300696"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}